Wright Medical begins buying up BioMimetic shares
Wright Medical Group picks up about 10 million shares of BioMimetic Therapeutics, for about a 36% stake, ahead of its planned merger next year.

Wright Medical [1] (NSDQ:WMGI [2]) began buying up shares of BioMimetic Therapeutics [3] (NSDQ:BMTI [4]), taking out a 36% stake in the regenerative medicine company, according to a regulatory filing.
Wright agreed last week to pay up to $390 million in cash, stock and milestone payments for BMTI, saying it plans to use the acquisition to bolster its foot and ankle healing business.
The Arlington, Tenn.-based medical device company now owns some 10.2 million shares of BioMimetic, according to the filing [5].